piribedil has been researched along with Aging in 7 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Certain clinical manifestations of Parkinson's disease (PD) (speech or/and balance disturbances) are not linked to brain dopamine deficiency." | 1.28 | Cardiac beta-adrenoceptor sensitivity and Parkinson's disease. ( Allain, H; Bentue-Ferrer, D; Decombe, R; Lemaitre, MH; Martinet, JP; Milon, D, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gierski, F | 1 |
| Peretti, CS | 1 |
| Ergis, AM | 1 |
| Marighetto, A | 1 |
| Valerio, S | 1 |
| Philippin, JN | 1 |
| Bertaina-Anglade, V | 1 |
| Drieu la Rochelle, C | 1 |
| Jaffard, R | 1 |
| Morain, P | 1 |
| Dourish, CT | 1 |
| Cooper, SJ | 1 |
| Bustany, P | 1 |
| Trenque, T | 1 |
| Crambes, O | 1 |
| Moulin, M | 1 |
| Ollat, H | 1 |
| Corbe, C | 1 |
| Arnaud, F | 1 |
| Brault, Y | 1 |
| Janiak-Bolzinger, C | 1 |
| Milon, D | 1 |
| Allain, H | 1 |
| Bentue-Ferrer, D | 1 |
| Martinet, JP | 1 |
| Lemaitre, MH | 1 |
| Decombe, R | 1 |
1 review available for piribedil and Aging
| Article | Year |
|---|---|
Dopaminergic insufficiency reflecting cerebral ageing: value of a dopaminergic agonist, piribedil.
Topics: Aged; Aged, 80 and over; Aging; Animals; Brain; Cognition; Dopamine; Humans; Middle Aged; Piribedil | 1992 |
1 trial available for piribedil and Aging
| Article | Year |
|---|---|
Effects of the dopamine agonist piribedil on prefrontal temporal cortical network function in normal aging as assessed by verbal fluency.
Topics: Affect; Aged; Aged, 80 and over; Aging; Dopamine Agonists; Double-Blind Method; Female; Humans; Male | 2007 |
5 other studies available for piribedil and Aging
| Article | Year |
|---|---|
Comparative effects of the dopaminergic agonists piribedil and bromocriptine in three different memory paradigms in rodents.
Topics: Aging; Animals; Antiparkinson Agents; Bromocriptine; Discrimination Learning; Disease Models, Animal | 2008 |
Effects of piribedil and of d-amphetamine on locomotor activity in immature rats.
Topics: Aging; Animals; Dextroamphetamine; Dose-Response Relationship, Drug; Male; Motor Activity; Piperazin | 1984 |
Restoration of brain protein synthesis in mature and aged rats by a DA agonist, piribedil.
Topics: Aging; Animals; Brain; Dopamine Agonists; Dose-Response Relationship, Drug; Male; Piribedil; Protein | 1995 |
Effect of a dopaminergic agonist, piribedil (Trivastal 50 mg LP), on visual and spatial integration in elderly subjects.
Topics: Aged; Aging; Contrast Sensitivity; Dopamine; Female; Humans; Male; Middle Aged; Piribedil; Retina; S | 1992 |
Cardiac beta-adrenoceptor sensitivity and Parkinson's disease.
Topics: Aged; Aging; Blood Pressure; Bromocriptine; Dose-Response Relationship, Drug; Female; Heart Rate; Hu | 1991 |